Dr May Mabro

- Spécialité
- Oncologue médical, expert digestif
- Hôpital
- Hôpital Foch (Suresnes)
- Derniers articles
-
- The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors. (2 janv. 2025)
- FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial. (1 juin 2024)
- Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial. (1 déc. 2023)
- Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study. (1 mai 2023)
- From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics. (28 août 2022)